Invesco Ltd. Bio Rad Laboratories, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 40,312 shares of BIO stock, worth $12.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,312

Previous 548,048 92.64%

Holding current value

$12.9 Million

Previous $150 Million 90.99%

% of portfolio

0.0%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$263.97 - $344.64 $134 Million - $175 Million	-507,736 Reduced 92.64%	40,312 $13.5 Million
Q2 2024 Aug 13, 2024	BUY	$268.26 - $339.48 $23.3 Million - $29.5 Million	87,042 Added 18.88%	548,048 $150 Million
Q1 2024 May 14, 2024	BUY	$304.11 - $351.99 $995,960 - $1.15 Million	3,275 Added 0.72%	461,006 $159 Million
Q4 2023 Feb 12, 2024	BUY	$269.37 - $365.04 $30.8 Million - $41.7 Million	114,269 Added 33.27%	457,731 $148 Million
Q3 2023 Nov 13, 2023	BUY	$350.25 - $422.63 $8.95 Million - $10.8 Million	25,562 Added 8.04%	343,462 $123 Million
Q2 2023 Aug 11, 2023	BUY	$359.49 - $486.4 $33.7 Million - $45.6 Million	93,765 Added 41.83%	317,900 $121 Million
Q1 2023 May 12, 2023	SELL	$418.69 - $503.0 $23.6 Million - $28.3 Million	-56,325 Reduced 20.08%	224,135 $107 Million
Q4 2022 Feb 13, 2023	BUY	$351.71 - $456.01 $26.8 Million - $34.8 Million	76,260 Added 37.35%	280,460 $118 Million
Q3 2022 Nov 14, 2022	SELL	$412.59 - $563.26 $46.4 Million - $63.4 Million	-112,492 Reduced 35.52%	204,200 $85.2 Million
Q2 2022 Aug 15, 2022	SELL	$463.67 - $597.16 $16.4 Million - $21.1 Million	-35,408 Reduced 10.06%	316,692 $157 Million
Q1 2022 May 16, 2022	BUY	$524.57 - $735.42 $18.7 Million - $26.2 Million	35,635 Added 11.26%	352,100 $198 Million
Q4 2021 Feb 14, 2022	SELL	$708.84 - $794.68 $38.7 Million - $43.4 Million	-54,578 Reduced 14.71%	316,465 $239 Million
Q3 2021 Nov 15, 2021	BUY	$657.71 - $825.77 $17.8 Million - $22.3 Million	27,012 Added 7.85%	371,043 $277 Million
Q2 2021 Aug 17, 2021	SELL	$576.64 - $649.04 $63.7 Million - $71.7 Million	-110,436 Reduced 24.3%	344,031 $222 Million
Q1 2021 May 17, 2021	SELL	$547.01 - $662.35 $57.9 Million - $70.1 Million	-105,782 Reduced 18.88%	454,467 $260 Million
Q4 2020 Feb 16, 2021	BUY	$510.68 - $643.45 $51.2 Million - $64.5 Million	100,298 Added 21.81%	560,249 $327 Million
Q3 2020 Nov 16, 2020	BUY	$454.43 - $535.6 $73.2 Million - $86.3 Million	161,101 Added 53.91%	459,951 $237 Million
Q2 2020 Aug 14, 2020	BUY	$334.87 - $493.06 $36 Million - $53 Million	107,460 Added 56.15%	298,850 $135 Million
Q1 2020 May 15, 2020	SELL	$320.01 - $409.07 $6.05 Million - $7.73 Million	-18,906 Reduced 8.99%	191,390 $67.1 Million
Q4 2019 Feb 14, 2020	SELL	$319.73 - $374.2 $4.21 Million - $4.93 Million	-13,176 Reduced 5.9%	210,296 $77.8 Million
Q3 2019 Nov 14, 2019	BUY	$304.55 - $345.24 $11.4 Million - $12.9 Million	37,484 Added 20.15%	223,472 $74.4 Million
Q2 2019 Aug 14, 2019	BUY	$286.93 - $312.59 $27.5 Million - $29.9 Million	95,768 Added 106.15%	185,988 $58.1 Million
Q1 2019 May 15, 2019	SELL	$224.3 - $317.41 $576,899 - $816,378	-2,572 Reduced 2.77%	90,220 $27.6 Million
Q4 2018 Feb 14, 2019	BUY	$220.1 - $309.0 $20.4 Million - $28.7 Million	92,792 New	92,792 $21.5 Million

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.3M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $7.89B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account